Amoeba Eats Cells Alive

The intestinal parasite Entamoeba histolytica kills host cells by tearing pieces from them, which it then eats.

Written byEd Yong
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Entamoeba histolytica (green) ingesting bites of human T cells (purple).KATHERINE RALSTONFor decades, scientists assumed that the intestinal parasite Entamoeba histolytica killed human tissues with toxic molecules before ingesting them. They were wrong; it’s actually the other way around, according to a study published in Nature today (April 9).

Katherine Ralston, a postdoctoral researcher at the University of Virginia, has shown that E. histolytica—a single-celled amoeba—tears chunks from host cells and eats them. These attacks eventually kill the cell, at which point the parasite moves on. E. histolytica is the only parasite known to attack tissues in this way—a process known as trogocytosis, after “trogo,” the Greek word for “nibble.”

“It was a complete surprise,” said Virginia’s William Petri, Jr., who led the study. “I have focused my professional career on studying this parasite and I hadn’t appreciated it, nor had anyone else in the field. Katie [Katherine] came into the lab and took a fresh look at things.”

Ralston made her discovery after watching the amoebae under a microscope, while they were attacking ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies